foxo4-dri senolytic 2023 2024 Peptide Inhibitors Targeting FOXO4-p53 Interactions and Inducing Senescent Cancer Cell-specific Apoptosis The disordered p53 transactivation domain
The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4 DRI Nature Communications Cellular Senescence in Health, Disease, and Lens Aging Frontiers FOXO4 DRI regulates endothelial cell senescence via the P53 signaling pathway Senotherapy for chronic lung disease ScienceDirect
Pay in 4 interest-free payments of $6.21 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9



